Giuseppe Placidi | Medical Imaging | Best Research Article Award

Assoc. Prof. Dr. Giuseppe Placidi | Medical Imaging | Best Research Article Award

Professor | University of L’Aquila | Italy

Assoc. Prof. Dr. Giuseppe Placidi is an accomplished researcher whose work spans artificial intelligence, biomedical engineering, and human-computer interaction, with a strong emphasis on translational applications. His research demonstrates a rare combination of methodological innovation and practical impact, exemplified by his development of a lightweight convolutional neural network (CNN) for detecting COVID-19 from chest CT scans, which offers rapid and accurate diagnostic capabilities in clinical settings. In addition, he has contributed significantly to emotion recognition in human-robot interaction, advancing understanding of how AI systems can interpret and respond to human affective states. His work on EEG-based brain-computer interfaces driven by self-induced emotions highlights his expertise in integrating neurophysiological data with real-time computational algorithms, paving the way for more responsive and adaptive BCI systems. Beyond AI and neuroengineering, he has investigated neurocognitive function using semi-immersive virtual reality tasks combined with functional near-infrared spectroscopy, revealing insights into prefrontal cortex activation during complex motor tasks. Furthermore, his clinical research on gender differences in osteoporosis contributes to the understanding of disease mechanisms and patient-specific healthcare strategies. Published in high-impact journals such as Pattern Recognition Letters, Frontiers in Robotics and AI, and Computer Methods and Programs in Biomedicine, Dr. Placidi’s work is widely cited and recognized for its scientific rigor, interdisciplinary breadth, and societal relevance. His research consistently bridges cutting-edge computational methods with real-world applications, making him an exemplary candidate for recognition in research excellence.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

Polsinelli, M., Cinque, L., & Placidi, G. (2020). A light CNN for detecting COVID-19 from CT scans of the chest. Pattern Recognition Letters, 140, 95–100.

Spezialetti, M., Placidi, G., & Rossi, S. (2020). Emotion recognition for human-robot interaction: Recent advances and future perspectives. Frontiers in Robotics and AI, 7, 532279.

Iacoviello, D., Petracca, A., Spezialetti, M., & Placidi, G. (2015). A real-time classification algorithm for EEG-based BCI driven by self-induced emotions. Computer Methods and Programs in Biomedicine, 122(3), 293–303.

Moro, S. B., Bisconti, S., Muthalib, M., Spezialetti, M., Cutini, S., Ferrari, M., … Placidi, G. (2014). A semi-immersive virtual reality incremental swing balance task activates prefrontal cortex: A functional near-infrared spectroscopy study. NeuroImage, 85, 451–460.

De Martinis, M., Sirufo, M. M., Polsinelli, M., Placidi, G., Di Silvestre, D., & Ginaldi, L. (2020). Gender differences in osteoporosis: A single-center observational study. The World Journal of Men’s Health, 39(4), 750.

Libaihe Jing | Medical Technology | Best Researcher Award

[ays_poll id=1]

Dr. Libaihe Jing | Medical Technology | Best Researcher Award

Assistant Researcher, Lanzhou University, China

Dr. Libaihe Jing is an emerging researcher in medical technology, specializing in cancer genetics, gastric tumor biology and molecular mechanisms of disease progression. He earned his Ph.D. in Zoology from Lanzhou University in 2023, following a Master’s degree in Molecular Biology and Biochemistry from Lanzhou University of Technology in 2016 and a Bachelor’s degree in Life Sciences from Hubei University of Science and Technology in 2013. Currently, he serves as an Assistant Researcher at the Institute of Digestive System Tumors, Second Hospital of Lanzhou University, where he is also pursuing postdoctoral studies since 2024. His research interests focus on the interaction of genetic polymorphisms and environmental factors in gastric cancer, environmental tumor prevention, precision medicine and biotechnology innovation. Dr. Libaihe Jing has led multiple prestigious projects as Principal Investigator, including the National Natural Science Foundation-funded study on ITGB2 gene SNP and Helicobacter pylori interaction, international cooperation projects and Gansu Province’s Chief Scientist Project. His skills include molecular biology, bioinformatics, tumor biomarker discovery and translational medicine. With 4 Scopus-indexed publications, 10 citations and an h-index of 2, he is building a promising research profile. Dr. Jing has received recognition through leadership roles in scientific projects, highlighting his strong potential to advance cancer research and global medical technology innovation.

Profile: Scopus | ORCID

Featured Publications

  • Jing, L., Xu, J., Cai, J., Huang, S., Qiao, X., & Wan, F. (2024). Morphologic and mechanical adaptive variations in Saiga tatarica calcaneus: A model for interpreting the bone functional adaptation of wild artiodactyl in captivity. Veterinary World, 17, 448–461.

  • Jing, L., He, P., Ding, D., Qu, C., Shao, B., Ma, J., & Wang, J. (2021). Osteomorphological features of the hind limb bones of Saiga antelope (Saiga tatarica). Anatomia, Histologia, Embryologia, 50, 32–42.

  • Wang, J., Jing, L., Zheng, Y., He, P., Zhang, Y., & Zhou, Y. (2021). ER-α expression in the hypothalamus–pituitary–gonad axis of the Bactrian camel (Camelus bactrianus). Journal of Camel Practice and Research, 28, 25–32.

  • Liu, Z., Gao, X., Wan, F., Ma, X., Ding, M., & Jing, L. (2025). Assessing the impact of long-term captivity on Saiga antelope calcaneus mechanical characteristics by three-dimensional finite element simulation. Research in Veterinary Science, 195, 105858.

 

Kaveh Karami | Health Monitoring | Best Researcher Award

Assoc. Prof. Dr. Kaveh Karami | Health Monitoring | Best Researcher Award

Associate Professor at University of Kurdistan, Iran.

Dr. Kaveh Karami is an esteemed Associate Professor in the Department of Civil Engineering at the University of Kurdistan. His research is internationally recognized in the areas of Structural Dynamics, Structural Health Monitoring (SHM), System Identification, and Adaptive Structures. With over 260 citations and an h-index of 8, he has built a reputable academic profile in smart structural systems and nonlinear control. His innovative contributions span semi-active control, online system identification, wavelet analysis, and vision-based damage detection. Dr. Karami collaborates actively with international experts and serves as a key contributor to the advancement of intelligent infrastructure. His work integrates theoretical models with real-world structural systems, bridging academia and practical engineering solutions. As a prolific author, he continues to push the boundaries of resilient and adaptive civil infrastructure, combining digital technologies with structural engineering principles to ensure safety, sustainability, and smart performance in modern constructions.

Professional Profile

Scopus

Orcid

Google scholar

Education 

Dr. Kaveh Karami holds a strong academic foundation in civil and structural engineering. Although specific degree and institutional information is not detailed in the provided profile, his expertise clearly reflects advanced graduate-level research training and academic excellence in the fields of structural dynamics, smart materials, and control systems. His career progression into an Associate Professorship at the University of Kurdistan signals completion of a Ph.D. and significant postdoctoral contributions. Throughout his academic journey, Dr. Karami has specialized in adaptive structures, system identification, and semi-active control. His education likely emphasized mathematical modeling, computational engineering, and signal processing for structural applications. His consistent publication record and leadership in advanced research projects suggest not only technical mastery but also an educational background that combines strong theoretical knowledge with applied innovation, aligning with modern challenges in structural monitoring and seismic protection.

Professional Experience 

Dr. Karami currently serves as an Associate Professor in the Department of Civil Engineering at the University of Kurdistan. With a deep focus on structural control and health monitoring, he has played pivotal roles in academic research, mentoring graduate students, and leading interdisciplinary projects. His experience includes developing and applying advanced algorithms for damage detection, adaptive stiffness mechanisms, and subpixel motion estimation using vision-based technologies. He has published extensively in peer-reviewed journals, collaborated with national and international teams, and contributed to high-impact engineering conferences. Dr. Karami’s work addresses the integration of smart sensors, control theory, and structural mechanics to create intelligent, damage-resilient infrastructure. His professional trajectory demonstrates a balance of academic teaching, hands-on research, and project supervision, making him a leader in the next generation of civil infrastructure innovation.

Research Interest 

Dr. Karami’s research focuses on intelligent and adaptive civil engineering systems. His core areas include nonlinear structural control, semi-active tuned mass dampers, structural health monitoring (SHM), damage detection using wavelet and sparse component analysis, and vision-based motion tracking. A hallmark of his work is the integration of real-time system identification algorithms with smart materials and adaptive mechanisms to enhance the resilience of civil structures. He explores how technologies like digital image correlation, video-based modal analysis, and Markov parameter estimation can improve early detection of structural damage. His goal is to develop low-cost, high-accuracy, and scalable systems for infrastructure safety. Through extensive modeling, simulation, and experimental validation, Dr. Karami pushes the boundaries of how built environments respond to dynamic loads, seismic activity, and environmental degradation. His research directly contributes to smarter, safer, and more sustainable infrastructure systems worldwide.

Publications Top Noted

Nonlinear structural control using integrated DDA/ISMP and semi-active tuned mass damper
Authors: K. Karami, S. Manie, K. Ghafouri, S. Nagarajaiah
Cited by: 47
Year: 2019

Developing a Smart Structure Using Integrated Subspace-Based Damage Detection and Semi-Active Control
Authors: K. Karami, S. Akbarabadi
Cited by: 47
Year: 2016

On‐line system identification of structures using wavelet‐Hilbert transform and sparse component analysis
Authors: K. Karami, P. Fatehi, A. Yazdani
Cited by: 33
Year: 2020

Decreasing the damage in smart structures using integrated online DDA/ISMP and semi-active control
Authors: K. Karami, F. Amini
Cited by: 31
Year: 2012

Developing a semi-active adjustable stiffness device using integrated damage tracking and adaptive stiffness mechanism
Authors: S. Azizi, K. Karami, S. Nagarajaiah
Cited by: 29
Year: 2021

Damage detection algorithm based on identified system Markov parameters (DDA/ISMP) in building structures with limited sensors
Authors: F. Amini, K. Karami
Cited by: 20
Year: 2012

Capacity design by developed pole placement structural control
Authors: F. Amini, K. Karami
Cited by: 19
Year: 2011

Developing a smart structure using integrated DDA/ISMP and semi-active variable stiffness device
Authors: K. Karami, S. Nagarajaiah, F. Amini
Cited by: 14
Year: 2016

Conclusion 

Dr. Kaveh Karami is a highly accomplished academic and researcher whose innovative work in structural health monitoring, damage detection, and adaptive structural systems is advancing the state of civil engineering. His consistent publication in high-impact journals, deep technical expertise, and contributions to intelligent infrastructure mark him as an exceptional candidate for the Best Researcher Award.

With his solid foundation and forward-looking research trajectory, Dr. Karami is well-positioned to continue influencing both academic and engineering communities, globally and locally. Recognition through this award would be both timely and well-deserved.

Dr. Ronghua Jin | Drug Delivery System | Best Researcher Award

Dr. Ronghua Jin | Drug Delivery System | Best Researcher Award

Dr. Ronghua Jin, Guangxi Medical University, China

Dr. Ronghua Jin is a distinguished researcher in nanomedicine, drug delivery systems, and cancer therapy. He earned his Ph.D. in Chemical Engineering from Xi’an Jiaotong University, focusing on tumor microenvironment-triggered therapeutic platforms. With an M.D. in Physical Chemistry from South China University of Technology and a Bachelor’s in Applied Chemistry from Jiujiang University, Dr. Jin’s expertise spans theranostics and polymer-based drug delivery. As a Principal Investigator, he has led multiple nationally funded projects, developing targeted nanomedicine strategies for liver cancer treatment. His pioneering work in self-delivery nanomedicine and combined chemotherapy approaches has earned him recognition in the scientific community, making significant contributions to personalized cancer treatment and molecular-targeted therapies.

🌍 Professional Profile:

Orcid

Scopus

🏆 Suitability for the Best Researcher Award

Dr. Ronghua Jin’s groundbreaking research in nanomedicine and cancer therapy makes him an outstanding candidate for the Best Researcher Award. His expertise in drug delivery systems and theranostics has led to innovative advancements, including esterase-responsive polymer prodrug delivery and self-delivery nanomedicine. As a Principal Investigator of multiple national and institutional research grants, he has secured significant funding to develop targeted therapies for liver cancer. His work bridges chemistry, nanotechnology, and medicine, enhancing the effectiveness of chemotherapeutic and sonodynamic treatments. With a strong publication record and notable contributions to molecular-targeted cancer therapies, Dr. Jin exemplifies excellence in research, making him highly deserving of this prestigious award.

🎓 Education 

Dr. Ronghua Jin holds a Ph.D. in Chemical Engineering from Xi’an Jiaotong University (2016–2019), where he developed tumor microenvironment-triggered multimodal therapeutic platforms under the mentorship of Prof. Xin Chen. He earned his M.D. in Physical Chemistry from South China University of Technology (2008–2011), focusing on ionic liquid-assisted extraction of active pharmaceutical compounds, advised by Prof. Xiaoning An. His academic journey began with a Bachelor’s in Applied Chemistry from Jiujiang University (2004–2008), where he built a strong foundation in chemical applications for medicinal research. His interdisciplinary education has enabled him to integrate chemistry, nanotechnology, and biomedical sciences to develop novel drug delivery and cancer therapy systems.

🏢 Research Experience 

Dr. Ronghua Jin has extensive research experience in nanomedicine, polymer drug delivery, and cancer therapy. As a Principal Investigator, he has led multiple research projects, including a National Natural Science Foundation of China (NSFC) project (CNY 320,000) on esterase-responsive polymer prodrug delivery for liver cancer therapy. He is also leading a High-Level Talent Project at Guangxi Medical University (CNY 200,000) and a Traditional Chinese Medicine molecular biology research project (CNY 30,000). His work focuses on self-delivery nanomedicine, combining chemotherapy and sonodynamic therapy for targeted liver cancer treatment. His expertise in nanotechnology-driven drug delivery platforms has significantly contributed to advancing personalized medicine and molecular-targeted cancer therapies.

🏅 Awards and Honors

Dr. Ronghua Jin has received several prestigious research grants and honors for his innovative contributions to nanomedicine and drug delivery systems. He is a Principal Investigator on multiple national and institutional research projects, securing funding from NSFC, Guangxi Medical University, and Traditional Chinese Medicine Treatment Research Programs. His work on esterase-responsive polymer prodrug delivery and self-delivery nanomedicine has been recognized for its breakthrough potential in liver cancer treatment. Dr. Jin has been invited to present his findings at leading international conferences, and his research has been published in top-tier journals. His contributions to theranostics, cancer therapy, and nanomedicine make him a highly respected figure in the field.

🔬 Research Focus 

Dr. Ronghua Jin’s research specializes in nanomedicine, drug delivery systems, cancer therapy, and theranostics. His work integrates chemistry, biomedical engineering, and nanotechnology to develop targeted therapies for liver cancer. A key focus is on esterase-responsive polymer prodrug delivery, enhancing chemotherapy and sonodynamic treatments. He is also pioneering self-delivery nanomedicine, enabling drugs to actively transport and target cancer cells without external carriers. His research aims to improve the efficiency and precision of drug delivery, reducing side effects and enhancing treatment outcomes. Through his work, he contributes to the advancement of personalized medicine, molecular-targeted therapies, and multi-modal cancer treatment strategies.

📊 Publication Top Notes:

  1. Antibacterial, Nontoxic, Antifreezing, and Self-Adhesive Conductive Eutectogel for Strain Sensor

    • Year: 2025

  1. Amelioration of Osteoarthritis through Salicylic Acid Nano-Formulated Self-Therapeutic Prodrug

    • Year: 2024

  2. T Cell-Depleting Nanoparticles Ameliorate Bone Loss by Reducing Activated T Cells and Regulating the Treg/Th17 Balance

    • Year: 2021

  3. Multifunctional Hierarchical Nanohybrids Perform Triple Antitumor Theranostics in a Cascaded Manner for Effective Tumor Treatment

    • Year: 2021

  1. 2D PtS Nanorectangles/g-C₃N₄ Nanosheets with a Metal Sulfide–Support Interaction Effect for High-Efficiency Photocatalytic H₂ Evolution

    • Year: 2021

 

 

Assoc. Prof. Dr. Marta Slavkova | Pharmaceutical Technology | Best Researcher Award

Assoc. Prof. Dr. Marta Slavkova | Pharmaceutical Technology | Best Researcher Award

Assoc. Prof. Dr. Marta Slavkova, Medical University of Sofia, Bulgaria

Assoc. Prof. Dr. Marta Slavkova is an esteemed pharmaceutical researcher specializing in Pharmaceutical Technology and Biopharmacy. With a Ph.D. and ongoing specialization in Toxicology and Toxicological Analysis, she has made significant contributions to nanoparticulate drug delivery systems. Her research focuses on improving chemotherapeutics’ efficacy while reducing off-target effects. She has been a DAAD scholar in Düsseldorf, Germany, and has actively participated in international conferences. As a reviewer for WOS-indexed journals, she plays a crucial role in scientific advancements. Fluent in English and German, she teaches master’s students in Pharmaceutical Technology and continues to explore innovative drug delivery systems.

🌍 Professional Profile:

Google Scholar

Orcid

Scopus

🏆 Suitability for Best Researcher Award

Dr. Slavkova’s research in Medical and Pharmaceutical Technology, particularly in nanoparticulate drug delivery systems, showcases groundbreaking advancements in drug targeting and biopharmaceutical characterization. Her expertise in developing novel nanocarriers, including mesoporous silica and lipid-based nanoparticles, enhances therapeutic efficacy and safety. Her international collaborations, DAAD research scholarship, and extensive publication record make her a distinguished candidate for the Best Researcher Award. With hands-on experience in ISO quality standards, manuscript reviewing for WOS-indexed journals, and active participation in global conferences, Dr. Slavkova is an influential researcher dedicated to the progress of pharmaceutical sciences.

🎓 Education 

Dr. Slavkova earned her Ph.D. in Pharmaceutical Technology with a specialization in Biopharmacy. She is currently advancing her expertise in Toxicology and Toxicological Analysis. Her academic achievements include a DAAD scholarship for a 10-month research grant in Düsseldorf, Germany (2014-2015). Additionally, she has completed an auditor course in ISO 9001:2015 and ISO 19011:2018, equipping her with quality management expertise. Her extensive education and professional training allow her to bridge scientific research with industry standards. Fluent in English and German, she integrates international knowledge into her research and teaching, further strengthening her academic and professional profile.

👨‍🏫 Experience

Dr. Slavkova is an experienced researcher and academic, currently engaged in nanoparticulate drug delivery systems. She teaches Pharmaceutical Technology to master’s students and contributes significantly to pharmaceutical research. Her work includes developing novel drug carriers for parenteral, dermal, and oral applications, particularly for chemotherapeutics and natural bioactive compounds. She has participated in multiple international conferences, presenting her findings on improving drug efficacy and minimizing side effects. As a reviewer for WOS-indexed journals, she evaluates cutting-edge research, ensuring the highest quality standards. Her background in ISO auditing adds another layer of expertise to her scientific and professional endeavors.

🏅 Awards and Honors 

Dr. Slavkova has received numerous accolades for her contributions to pharmaceutical research. She was awarded a prestigious DAAD scholarship for a research grant in Düsseldorf, Germany (2014-2015). She has been an invited speaker at various international conferences, showcasing her expertise in nanoparticle drug delivery systems. Her active role as a reviewer for high-impact WOS-indexed journals highlights her influence in the scientific community. Additionally, she has been recognized for her contributions to pharmaceutical education, mentoring master’s students in advanced pharmaceutical technologies. Her interdisciplinary approach to drug delivery research has earned her recognition from both academic and industry professionals.

🔬 Research Focus 

Dr. Slavkova’s research revolves around nanoparticulate drug delivery systems, targeting various administration routes such as parenteral, dermal, and oral. She specializes in mesoporous silica nanoparticles, polymer nanoparticles, lipid nanocarriers, and hybrid nanoparticle systems. Her work aims to enhance chemotherapeutic efficacy while reducing systemic toxicity. Additionally, she investigates the biomedical potential of natural compounds like curcumin, quercetin, and berberine. Her expertise in biopharmaceutical characterization allows her to develop innovative drug targeting methods. With a strong focus on medical and pharmaceutical technology, her research contributes to the advancement of precision medicine and targeted therapies.

📖 Publication Top Notes

  • Orodispersible Drug Formulations for Children and Elderly

    • Year: 2015
    • Citations: 268
  • Gel Formulations for Topical Treatment of Skin Cancer: A Review

    • Year: 2023
    • Citations: 32
  • Superior Proapoptotic Activity of Curcumin-Loaded Mixed Block Copolymer Micelles with Mitochondrial Targeting Properties

    • Year: 2018
    • Citations: 21
  • A Novel Approach for Fabricating Nanocomposite Materials by Embedding Stabilized Core-Shell Micelles into Polysaccharide Cryogel Matrix

    • Year: 2018
    • Citations: 20
  • 10 Years EU Regulation of Pediatric Medicines–Impact on Cardiovascular Drug Formulations

    • Year: 2018
    • Citations: 14